Eli Lilly completes $1.04bn acquisition of Prevail Therapeutics to expand gene therapy program

Eli Lilly and Company has officially finalized its acquisition of Prevail Therapeutics in a deal valued at up to $1.04 billion. This acquisition represents a ... Read More